DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE

DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE

Aim. In patients with chronic heart failure (CHF) of ischemic aetiology, to assess the dynamics of heart rate variability (HRV) and ventricular ectopic activity during the complex, ivabradine-including therapy. Material and methods. In total, 90 patients with CHF and stable angina pectoris were exam...

Full description

Bibliographic Details
Main Authors:	M. V. Surovtseva, N. A. Koziolova, A. I. Chernyavina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2012-12-01
Series:	Российский кардиологический журнал
Subjects:	heart failure heart rate variability ventricular ectopic activity complex treatment ivabradine
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1305

Similar Items

Ivabradine therapy and correction of the target organ pathology in patients with ischemic chronic heart failure
by: M. V. Surovtseva, et al.
Published: (2013-06-01)

ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE
by: M. V. Surovtseva, et al.
Published: (2015-12-01)

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01)

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE IVABRADINE AND HEART RATE REDUCTION IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01)

Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure
by: Korhan Soylu, et al.
Published: (2020-08-01)

Ivabradine in Chronic Heart Failure
by: Hadeer Eid, et al.
Published: (2020-06-01)

Efficacy and safety evaluation of ivabradine in patients with non-ischemic heart failure
by: LIU Ying-xian, SONG Yan-jun, CHEN Wei, LIN Xue, LAI Jin-zhi, LI Jing-yi, WU Wei
Published: (2021-11-01)

Efficacy of ivabradine in idiopathic dilated cardiomyopathy patients with chronic heart failure
by: Sherief Mansour, et al.
Published: (2011-06-01)

Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function
by: Giuseppe Cocco, et al.
Published: (2013-11-01)

IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01)

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
by: Ying‐Hsiang Lee, et al.
Published: (2021-04-01)

The role of heart rate and ivabradine in acute heart failure
by: Edoardo Sciatti, et al.
Published: (2019-10-01)

Early administration of ivabradine in patients admitted for acute decompensated heart failure
by: Teng-Yao Yang, et al.
Published: (2022-11-01)

Effectiveness and safety of ivabradine in Chinese patients with chronic heart failure: an observational study
by: Jingmin Zhou, et al.
Published: (2024-04-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

The effect of ivabradine on hospitalization of heart failure patients: A retrospective cohort study
by: Sara Al-Balushi, et al.
Published: (2021-01-01)

Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
by: Yu‐Sheng Lin, et al.
Published: (2022-08-01)

Advances in the management of heart failure: the role of ivabradine
by: Müller-Werdan U, et al.
Published: (2016-11-01)

Epidemiologic surveillance on quality of life in patients with systolic heart failure after treatment with the selective heart rate inhibitor ivabradine
by: M Srinivasa Rao, et al.
Published: (2017-01-01)

Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients
by: Hadeer Eid, et al.
Published: (2020-12-01)

Effect of Ivabradine on Cardiac Ventricular Arrhythmias: Friend or Foe?
by: Marta Oknińska, et al.
Published: (2021-10-01)

IF CHANNEL INHIBITOR IVABRADINE AND CHRONIC HEART FAILURE MANAGEMENT: FROM DISCUSSION TO ACTION
by: Yu. M. Lopatin
Published: (2012-08-01)

Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial)
by: Amr Abdin, et al.
Published: (2023-10-01)

A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
by: David E. Lanfear, et al.
Published: (2020-08-01)

The myocardial remodeling at ischemic chronic heart failure: the features of Ivabradine influence in experimental model
by: S. V. Fedorov, et al.
Published: (2016-12-01)

The effect of ivabradine therapy on dilated cardiomyopathy patients with congestive heart failure: a systematic review and meta-analysis
by: Juntao Yang, et al.
Published: (2023-10-01)

Ivabradine in patients with heart failure: a systematic literature review
by: Zeba M. Khan, et al.
Published: (2023-12-01)

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease
by: Hosam Zaky, et al.
Published: (2013-01-01)

Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction
by: Krittayaphong R, et al.
Published: (2019-12-01)

COMPARATIVE EVALUATION OF THE EFFECT OF COMBINATION THERAPY WITH BISOPROLOL BISOPROLOL MONOTHERAPY AND IVABRADINE ON LEFT VENTRICULAR SYSTOLIC FUNCTION, CENTRAL HEMODYNAMICS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE, WITH MODERATELY REDUCED EJECTION
by: /. Katsytadze
Published: (2015-09-01)

Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT‐AHF trial
by: Yang Su, et al.
Published: (2020-12-01)

Initiation of ivabradine in cardiogenic shock
by: Michael H. Chiu, et al.
Published: (2019-10-01)

The effect of ivabradine as part of standard therapy on vascular endothelial function and cardiac electrical instability in patients with post-infarction cardiosclerosis and heart failure
by: A. A. Abdullaev, et al.
Published: (2020-02-01)

Heart Rate Reduction and Outcomes in Heart Failure Outpatients
by: Felix Memenga, et al.
Published: (2023-10-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Zheleznyakova, et al.
Published: (2012-02-01)

Use of ivabradine in a critically ill pediatric patient with recalcitrant ectopic atrial tachycardia and complex congenital heart disease
by: Gretchen Hackett, DO, MS, et al.
Published: (2022-06-01)

Modern opportunities of heart rate regulation in coronary heart disease
by: N. Sh. Zagidullin, et al.
Published: (2013-10-01)

PR Interval as a Novel Therapeutic Target of Ivabradine Therapy—Prognostic Impact of Ivabradine-Induced PR Prolongation in Heart Failure Patients
by: Riona Yamamoto, et al.
Published: (2024-01-01)

Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
by: Nadia Bouabdallaoui, et al.
Published: (2019-12-01)